APA

Johnson D. S., Choi C., Fay L. K., Favor D. A., Repine J. T., White A. D., Akunne H. C., Fitzgerald L., Nicholls K., Snyder B. J., Whetzel S. Z., Zhang L. & Serpa K. A. (20110815). Discovery of PF-00217830: aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder. : Bioorganic & medicinal chemistry letters.

Chicago

Johnson Douglas S, Choi Chung, Fay Lorraine K, Favor David A, Repine Joseph T, White Andrew D, Akunne Hyacinth C, Fitzgerald Lawrence, Nicholls Kim, Snyder Bradley J, Whetzel Steven Z, Zhang Liming and Serpa Kevin A. 20110815. Discovery of PF-00217830: aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder. : Bioorganic & medicinal chemistry letters.

Harvard

Johnson D. S., Choi C., Fay L. K., Favor D. A., Repine J. T., White A. D., Akunne H. C., Fitzgerald L., Nicholls K., Snyder B. J., Whetzel S. Z., Zhang L. and Serpa K. A. (20110815). Discovery of PF-00217830: aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder. : Bioorganic & medicinal chemistry letters.

MLA

Johnson Douglas S, Choi Chung, Fay Lorraine K, Favor David A, Repine Joseph T, White Andrew D, Akunne Hyacinth C, Fitzgerald Lawrence, Nicholls Kim, Snyder Bradley J, Whetzel Steven Z, Zhang Liming and Serpa Kevin A. Discovery of PF-00217830: aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder. : Bioorganic & medicinal chemistry letters. 20110815.